How to Read a Peptide Certificate of Analysis (COA)

A certificate of analysis, or COA, is a lot-specific summary of test results. It should help a laboratory decide whether a material meets predefined requirements for a particular use. A COA is not a substitute for understanding the test methods, and a polished document is not proof that every relevant quality attribute was measured.

The strongest way to read a peptide COA is in layers: first confirm traceability, then separate identity from purity and content, and finally decide whether the methods and results are fit for the intended experiment.

1. Confirm that the certificate belongs to the vial

Start with the identifiers. The product name, sequence or catalogue number and lot or batch number should match the container and purchase record. The certificate should identify the issuing organization, the date or version of the document and the tests performed. If the lot number is missing or does not match, the results cannot be confidently assigned to the vial in hand.

For modified peptides, check that the certificate states the relevant chemical form: terminal modifications, salt or counter-ion, isotopic label, disulfide status and other defined modifications. A sequence alone may not distinguish materials with different expected masses or physicochemical behaviour.

2. Read identity separately from purity

An identity test asks whether the material is the expected peptide. Mass spectrometry is commonly used. A useful COA reports the expected molecular mass, the observed result and enough method information to understand the comparison. Depending on ionization and charge state, the displayed mass-to-charge peaks will not necessarily equal the neutral molecular mass directly.

An HPLC or UHPLC purity result usually reports the principal peak as a percentage of integrated chromatographic area under specified conditions. This is a relative result. It depends on the column, gradient, mobile phases, temperature, detector, wavelength, run time, sample load and integration choices.

Identity by mass spectrometry does not prove that the entire sample is pure. Conversely, a large chromatographic peak at the expected retention time is not, on its own, definitive structural identification. Orthogonal evidence is valuable because different methods answer different questions.

3. Do not treat area percent as peptide content

One of the most common interpretation errors is reading “99% HPLC purity” as “99% of the vial mass is peptide.” Chromatographic area percent compares detected peaks under one method. Total weighed mass may also include water, counter-ions, residual solvents and material with a different detector response.

If an experiment depends on an accurately assigned amount, look for a separate content or concentration value and the method used to establish it. Amino acid analysis, quantitative NMR or another suitable quantitative procedure may be used depending on the material and purpose. The Clinical Proteomic Tumor Analysis Consortium’s consensus recommendations stress the importance of carefully characterized peptide reference materials and transparent preparation protocols for quantitative mass-spectrometry assays.

4. Look for the method, not only the number

For numerical results, distinguish display resolution from calibration and the uncertainty assigned to the result. Our laboratory measurement-uncertainty guide explains these terms and the questions to ask when coverage information is missing.

ICH Q2(R2) describes characteristics used to show that an analytical procedure is fit for purpose, including specificity or selectivity, accuracy and precision over the reportable range. A research COA will not always include a complete validation package, but it should still provide enough context to interpret the reported value.

For chromatographic purity, useful supporting information includes:

• method name or identifier and analytical technique;
• detection wavelength or detector type;
• acceptance criterion and numerical result;
• a chromatogram with labelled sample and lot;
• integration that includes relevant peaks and a defined reporting threshold;
• system-suitability or reference-standard information where applicable.

For mass spectrometry, look for the theoretical mass, observed mass or deconvoluted mass, ionization method and a spectrum that can be traced to the same lot. A statement such as “MS passed” without the expected and observed result provides less evidence than a transparent report.

Check that the method covers the sample

A technique name such as HPLC identifies an analytical approach, not its complete scope. Ask which substance or property the method measures, which sample types it covers, the applicable concentration range and any known interferences. The sample matrix is the material surrounding the substance being measured. Performance established for one matrix should not simply be assumed for another: extraction, recovery and interference can change. Eurachem recommends defining the method’s scope and establishing its working range for each covered matrix. Request the applicable method identifier and scope rather than treating an instrument name as evidence of suitability. Source: Eurachem 2025 method-validation guide, section 5.4 and Annex A.5.

Separate submitted information from measured findings

A sample description supplied by a customer is not necessarily a laboratory finding. Read who supplied the identifying information, who selected the sample and what the laboratory actually tested. NATA’s ISO/IEC 17025 assessment worksheet distinguishes customer-provided information from the laboratory’s responsibility for its report. It also addresses reports where the customer performed sampling: the results apply to the sample as received. Such a statement does not, by itself, establish that the tested portion represents every container in a batch. Keep this limitation alongside the result when reviewing the certificate. Source: NATA assessment worksheet, section 7.8.2.

Read the report status and qualifications

Check whether the document is preliminary, final, supplemented or replaced. A preliminary report may cover only completed portions of the work; a revised report should be traceable to the earlier document. Identify externally performed tests and retain relevant notes instead of copying only the headline number. NATA’s reporting guidance explains these distinctions for its accredited organisations. It also limits use of its endorsement to the applicable accreditation scope, subject to its stated exceptions. Do not infer that a laboratory logo or accreditation claim covers every test on a mixed report; check the relevant scope and ask the issuer to explain any ambiguity. Source: NATA, test reports explained.

Ask what a pass statement actually covers

A measured result and a statement that it meets a requirement are different information. For a pass or conformity statement, identify the particular results assessed, the specification used and the decision rule. A decision rule explains how measurement uncertainty is considered in that judgment; ILAC notes that there is no single rule suitable for every test. A pass against one defined requirement is therefore not a conclusion about unmeasured attributes or unrelated uses. If the basis is unclear, ask the issuing laboratory before relying on the statement. Source: ILAC G8, sections 2–3.

Before comparing certificates, record these five answers with the original documents:

• Which sample type, measured property and method scope does each result cover?
• Which identifiers came from the submitter, and which findings came from testing?
• What sampling limitations, method deviations or exclusions accompany the result?
• Is this the complete current report, including amendments and externally performed tests?
• If conformity is stated, which requirement and decision rule support it?

This is a practical reading checklist, not an accreditation audit or evidence that any supplier’s material has been tested. Missing context is a reason to seek clarification, not a reason to assume either a passing result or a failed test.

5. Review other attributes relevant to the experiment

Not every attribute belongs on every COA. The planned use determines what matters. Depending on the sequence and workflow, relevant tests may include water, residual solvents, counter-ion content, appearance, solubility, bioburden, endotoxin or sequence-specific structural checks. A claim should be interpreted only within the method and acceptance criterion shown.

Absence of a test result is not the same as a passing result. If a product page lists an attribute that is not present on the lot certificate, ask whether it was tested for that lot and request the applicable record before relying on it.

If a report says not detected, read the stated analytical limit and qualifiers with that result. Our guide to LOD, LOQ and not-detected laboratory results explains the questions to ask before treating two reports as comparable.

6. Watch for common COA red flags

• no lot or batch number, or a number that does not match the vial;
• generic results copied across lots without test dates;
• purity claims with no analytical method;
• a chromatogram that lacks sample identity, axes or peak integration;
• mass spectrometry reported only as “pass” with no expected and observed value;
• area-percent purity presented as total peptide content;
• results reported with implausible precision or without an acceptance criterion;
• a certificate that cannot be linked to the issuing laboratory or supplier record.

Turn the COA into a laboratory decision

To keep the reviewed document connected to later preparations and results, see the research peptide lot-traceability guide and its suggested receipt-to-result record fields.

Before opening the vial, compare the certificate with a written acceptance checklist based on intended use. Record the review, retain the original file and link the lot to subsequent preparation and experiment records. For critical quantitative work, supplier documentation may need to be supplemented with independent identity, purity or content testing.

References

1. International Council for Harmonisation. ICH Q2(R2): Validation of Analytical Procedures.
2. Hoofnagle AN, et al. Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. Clin Chem. 2016;62(1):48–69.